Nebivolol

5 trials 4 recruiting CCardiology

Filter these 5 trials by condition, phase, country and more.

Open in Search →

5 Registered trials

4 Recruiting

0 Completed trials

5 Sponsors

5 Countries

Phase III/IV

Phase IV

Phase III/IV: 1 Phase IV: 4

Sponsors using this IMP

Amsterdam UMC 1 Andrea Di Marco 1 Fakultni Nemocnice Ostrava 1 Medical University Of Vienna 1 Policlinico San Donato S.p.A. 1

All trials

5 total

Prevention of heart disease in heart-healthy patients with diabetes based on a special parameter (NT-proBNP) Pending

2024-519051-28-01 Phase IV 2 countries Medical University Of Vienna
Pharmacological optimization in prevention in Heart Failure: A Sex-gap? Recruiting

2025-520660-18-00 Phase IV 1 country Policlinico San Donato S.p.A.
Withdrawal of neurohormonal therapy in patients with non-ischemic cardiomyopathy, no late gadolinium enhancement, and negative genetic testi… Recruiting

2025-521780-12-00 Phase III/IV 1 country Andrea Di Marco
Optimal drug therapy for the suppression of ventricular arrhythmias in Andersen-Tawil syndrome and multifocal ectopic Purkinje-related prema… Recruiting

2024-510682-42-01 Phase IV 1 country Amsterdam UMC
Use of determination of drug levels to optimize pharmacotherapy of heart failure Recruiting

2023-506283-13-00 Phase IV 1 country Fakultni Nemocnice Ostrava

Showing 1–5 of 5 trials

← All drugs A–Z